Business Wire

NC-ATTINDAS-HYGIENE

12.1.2022 12:06:09 CET | Business Wire | Press release

Share
Attindas Hygiene Partners Announces Lower Carbon Footprint Protective Underwear Products Launching Across Europe

Attindas Hygiene Partners is proud to announce the launch of its reduced carbon emissions adult incontinence protective underwear throughout Europe. By utilizing the new product design, which uses ultrasonic bonding in place of traditional glue adhesive, Attindas is now able to measurably reduce greenhouse gas emissions, including carbon dioxide, to provide less environmental impact. This technology investment expands upon Attindas’ recent successful launches in North America and Spain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220112005197/en/

The new product design also improves user experience, providing a more comfortable, snug fit. By increasing elastic material from top to bottom throughout the product, it creates a protective underwear capable of fitting a wide range of body shapes and sizes.

“At Attindas we are driven to provide effective, affordable, and widely available solutions to help those with Adult Incontinence enjoy life with health, dignity, and comfort every day,” said Chad M. Lang, head of Global Marketing for Attindas. “This innovation in protective underwear delivers an experience that’s more like wearing traditional underwear for our consumers, while enhancing the sustainability profile of our product assortment. We’re excited for users of our protective underwear, and those retailer partner brands we support in Europe, to experience this new product, as we flow this innovation to them for their next purchase.”

Promotional video for Attends® Pull-On protective underwear:
https://youtu.be/Hqok7g5L1LY

About Attindas

Based in Raleigh, NC, USA, Attindas Hygiene Partners brings together a portfolio of companies including Attends Healthcare Products, Associated Hygienic Products, and HDIS in North America, and Laboratorios Indas and Attends Healthcare AB in Europe. Attindas designs, manufactures, and markets absorbent hygiene products for US, Canada, Europe and export markets worldwide. The company’s main business lines include adult incontinence and infant diapers, among other products, for the healthcare, retail, and direct-to-consumer channels under its well-known brands including Attends, Incopack, Indasec, Chelino, and Comfees. Attindas additionally supplies as a wide range of private label brands for retailers in North America and Europe. Learn more at www.attindas.com .

Attindas Hygiene Partners
8020 Arco Corporate Drive, Suite 200, Raleigh, NC 27617
919-237-4000
contact@attindas.com
www.attindas.com

Link:

ClickThru

Social Media:

https://www.facebook.com/attindas

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 20261.2.2026 08:00:00 CET | Press release

Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131322203/en/ Lorient’s low degree of modification delivers a smooth injection experience and high biocompatibility (Image: Lorient) The highlight was a session led by Dr. Jani van Loghem, a globally revered key opinion leader known for establishing international aesthetic safety protocols. His involvement provided a prestigious validation of the technical excellence of Lorient. Alongside him, prominent Korean medical experts Dr. Won Lee and Dr. Do Young Rhee shared clinical insights that drew widespread praise from the international medical community. Central to the academic discussions was Lorient’s "safety-first" philosophy for its premium HA filler ran

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye